HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Survivorship and Long-Term Care
Survivorship and Long-Term Care
- Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers.
- Quality of Life: Addressing the long-term physical, psychological, and social effects of cancer.
- Rehabilitation: Physical therapy, occupational therapy, and return to work programs.
- Fertility Preservation: Options for cancer patients before, during, and after treatment.
Survivorship and long-term care are critical aspects of cancer research, focusing on the health and well-being of individuals who have completed cancer treatment. Research in this area explores how survivors manage physical, emotional, and social challenges that arise post-treatment. Studies show that many cancer survivors face long-term side effects, including fatigue, pain, and emotional stress, which can affect their quality of life. Innovations in personalized care plans and supportive therapies, such as mental health counseling and rehabilitation, aim to address these challenges. Ongoing research seeks to enhance survivorship outcomes, improve long-term care strategies, and ensure survivors lead fulfilling lives after cancer.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation